catheter for the treatment of persistent AFib and ablation of cavotricuspid isthmus dependent atrial flutter using RF energy. In clinical trials, patients treated with the Sphere-9 catheter ...
the historical treatment (without much evidence to support it) has been verapamil. There is no thromboembolism risk in MAT, such as seen in atrial fibrillation or atrial flutter, as the atrium are ...
The AF was refractory to treatment with antiarrhythmic drugs. Pacemaker implantation for tachycardia–bradycardia syndrome was required as well as ablation for atrial flutter, and the patient ...
Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...
Atrial fibrillation is the most common arrhythmic ... it is imperative for the clinician to be informed about these arrhythmias and treatment considerations. This paper presents a basic review ...
If rate control is needed, the historical treatment (without much evidence to support it) has been verapamil. There is no thromboembolism risk in MAT such is seen in atrial fibrillation/flutter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results